tadalafil has been researched along with Cancer of Colon in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Abadi, AH; Abdel-Halim, M; Gary, BD; Piazza, GA; Tinsley, HN | 1 |
| Gao, Y; Kang, Y; Ma, X; Sun, ZJ; Xiong, H; Xu, Z; Xue, P; Zhang, T | 1 |
| Abadi, AH; Chang, WC; Chen, X; Clapper, ML; Gary, BD; Grizzle, WE; Gurpinar, E; Keeton, AB; Li, N; Li, Y; Moyer, MP; Piazza, GA; Tinsley, HN; Xi, Y; Zhu, B | 1 |
3 other study(ies) available for tadalafil and Cancer of Colon
| Article | Year |
|---|---|
Synthesis, molecular modeling and biological evaluation of novel tadalafil analogues as phosphodiesterase 5 and colon tumor cell growth inhibitors, new stereochemical perspective.
Topics: Carbolines; Cell Division; Colonic Neoplasms; HT29 Cells; Humans; Magnetic Resonance Spectroscopy; Models, Molecular; Phosphodiesterase Inhibitors; Spectrophotometry, Infrared; Stereoisomerism; Tadalafil | 2010 |
Supramolecular Tadalafil Nanovaccine for Cancer Immunotherapy by Alleviating Myeloid-Derived Suppressor Cells and Heightening Immunogenicity.
Topics: Colonic Neoplasms; Humans; Immunotherapy; Myeloid-Derived Suppressor Cells; Tadalafil; Tumor Microenvironment | 2021 |
Sulindac selectively inhibits colon tumor cell growth by activating the cGMP/PKG pathway to suppress Wnt/β-catenin signaling.
Topics: Antineoplastic Agents; Apoptosis; Caco-2 Cells; Carbolines; Cell Line; Cell Proliferation; Colonic Neoplasms; Cyclic GMP; Cyclic GMP-Dependent Protein Kinases; Cyclic Nucleotide Phosphodiesterases, Type 5; Cyclin D1; HCT116 Cells; HT29 Cells; Humans; Inhibitor of Apoptosis Proteins; Phosphodiesterase 5 Inhibitors; Piperazines; Purines; Sildenafil Citrate; Sulfones; Sulindac; Survivin; Tadalafil; Wnt Signaling Pathway | 2013 |